CT volume measurement for prognostic evaluation of unresectable hepatocellular carcinoma after TACE

World Journal of Gastroenterology

Volumn 16, Issue 16, 2010, Pages 2038-2045

  Zhang, Jia Wen ^a   Feng, Xiao Yuan ^a   Liu, Han Qiu ^a   Yao, Zhen Wei ^a   Yang, Yan Mei ^a   Liu, Bin ^b   Yu, Yong Qiang ^b  

^a FUDAN UNIVERSITY   (China)

^b ANHUI MEDICAL UNIVERSITY   (China)

Author keywords

Chemoemboliza tion; Computed tomography; Hepatocellular carcinoma; Prognosis; Tumor volume

Indexed keywords

ALPHA FETOPROTEIN; CISPLATIN; DOXORUBICIN; IODINATED POPPYSEED OIL; MITOMYCIN;

ADULT; AGE; AGED; ARTICLE; CANCER GROWTH; CANCER SIZE; CANCER SURVIVAL; CHEMOEMBOLIZATION; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG TISSUE LEVEL; FEMALE; GENDER; HUMAN; KAPLAN MEIER METHOD; LIVER CELL CARCINOMA; LIVER FUNCTION; MAJOR CLINICAL STUDY; MALE; METASTASIS; OVERALL SURVIVAL; PORTAL VEIN THROMBOSIS; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; PROTEIN ANALYSIS; SURVIVAL RATE;

EID: 77951956693     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v16.i16.2038     Document Type: Article

References (33)

1. Okuda K, Ohtsuki T, Obata H, Tomimatsu M, Okazaki N, Hasegawa H, Nakajima Y, Ohnishi K. Natural history of hepatocellular carcinoma and prognosis in relation to treatment. Study of 850 patients. Cancer 1985; 56: 918-928.
2. Taniguchi K, Nakata K, Kato Y, Sato Y, Hamasaki K, Tsuruta S, Nagataki S. Treatment of hepatocellular carcinoma with transcatheter arterial embolization. Analysis of prognostic factors. Cancer 1994; 73: 1341-1345.
3. Lin DY, Liaw YF, Lee TY, Lai CM. Hepatic arterial embolization in patients with unresectable hepatocellular carcinoma--a randomized controlled trial. Gastroenterology 1988; 94: 453-456.
4. Uchida H, Ohishi H, Matsuo N, Nishimine K, Ohue S, Nishimura Y, Maeda M, Yoshioka T. Transcatheter hepatic segmental arterial embolization using lipiodol mixed with an anticancer drug and Gelfoam particles for hepatocellular carcinoma. Cardiovasc Intervent Radiol 1990; 13: 140-145.
5. Zeman RK, Fox SH, Silverman PM, Davros WJ, Carter LM, Griego D, Weltman DI, Ascher SM, Cooper CJ. Helical (spiral) CT of the abdomen. AJR Am J Roentgenol 1993; 160: 719-725.
6. Jaffe CC. Measures of response: RECIST, WHO, and new alternatives. J Clin Oncol 2006; 24: 3245-3251.
7. Preda L, Lovati E, Chiesa F, Ansarin M, Cattaneo L, Fasani R, Gandini S, Flor N, Cornalba G, Bellomi M. Measurement by multidetector CT scan of the volume of hypopharyngeal and laryngeal tumours: accuracy and reproducibility. Eur Radiol 2007; 17: 2096-2102.
8. Lemke AJ, Brinkmann MJ, Schott T, Niehues SM, Settmacher U, Neuhaus P, Felix R. Living donor right liver lobes: preoperative CT volumetric measurement for calculation of intraoperative weight and volume. Radiology 2006; 240: 736-742.
9. Prasad SR, Jhaveri KS, Saini S, Hahn PF, Halpern EF, Sumner JE. CT tumor measurement for therapeutic response assessment: comparison of unidimensional, bidimensional, and volumetric techniques initial observations. Radiology 2002; 225: 416-419.
10. Sohaib SA, Turner B, Hanson JA, Farquharson M, Oliver RT, Reznek RH. CT assessment of tumour response to treatment: comparison of linear, cross-sectional and volumetric measures of tumour size. Br J Radiol 2000; 73: 1178-1184.
11. Zhu J, Leng X, Dong N, Qi G, Du R. [Measurement of liver volume and its clinical significance in cirrhotic patients] Zhonghua Waike Zazhi 1999; 37: 110-112.
12. Dachman AH, MacEneaney PM, Adedipe A, Carlin M, Schumm LP. Tumor size on computed tomography scans: is one measurement enough? Cancer 2001; 91: 555-560.
13. Ettinger DS, Leichner PK, Siegelman SS, Fishman EK, Klein JL, Order SE. Computed tomography assisted volumetric analysis of primary liver tumor as a measure of response to therapy. Am J Clin Oncol 1985; 8: 413-418.
14. Van Hoe L, Van Cutsem E, Vergote I, Baert AL, Bellon E, Dupont P, Marchal G. Size quantification of liver metastases in patients undergoing cancer treatment: reproducibility of one-, two-, and three-dimensional measurements determined with spiral CT. Radiology 1997; 202: 671-675.
15. Arimoto T. Significance of computed tomography-measured volume in the prognosis of cervical carcinoma. Cancer 1993; 72: 2383-2388.
16. Vogl TJ, Trapp M, Schroeder H, Mack M, Schuster A, Schmitt J, Neuhaus P, Felix R. Transarterial chemoembolization for hepatocellular carcinoma: volumetric and morphologic CT criteria for assessment of prognosis and therapeutic success-results from a liver transplantation center. Radiology 2000; 214: 349-357.
17. Kubota K, Ina H, Okada Y, Irie T. Growth rate of primary single hepatocellular carcinoma: determining optimal screening interval with contrast enhanced computed tomography. Dig Dis Sci 2003; 48: 581-586.
18. Breiman RS, Beck JW, Korobkin M, Glenny R, Akwari OE, Heaston DK, Moore AV, Ram PC. Volume determinations using computed tomography. AJR Am J Roentgenol 1982; 138: 329-333.
19. Nishimine K, Uchida H, Matsuo N, Sakaguchi H, Hirohashi S, Nishimura Y, Guo Q, Ohishi H, Nagano N, Yoshioka T. Segmental transarterial chemoembolization with Lipiodol mixed with anticancer drugs for nonresectable hepatocellular carcinoma: follow-up CT and therapeutic results. Cancer Chemother Pharmacol 1994; 33 Suppl: S60-S68
20. Monden M, Sakon M, Gotoh M, Kanai T, Umeshita K, Wang KS, Sakurai M, Kuroda C, Okamura J, Mori T. Selection of therapeutic modalities for hepatocellular carcinoma in patients with multiple hepatic lesions. Cancer Chemother Pharmacol 1992; 31 Suppl: S38-S44
21. Saini S. Radiologic measurement of tumor size in clinical trials: past, present, and future. AJR Am J Roentgenol 2001; 176: 333-334.
22. Soutter WP, Hanoch J, D'Arcy T, Dina R, McIndoe GA, De-Souza NM. Pretreatment tumour volume measurement on high-resolution magnetic resonance imaging as a predictor of survival in cervical cancer. BJOG 2004; 111: 741-747.
23. Chong VF, Zhou JY, Khoo JB, Huang J, Lim TK. Nasopharyngeal carcinoma tumor volume measurement. Radiology 2004; 231: 914-921.
24. Friedman MA, Resser KJ, Marcus FS, Moss AA, Cann CE. How accurate are computed tomographic scans in assessment of changes in tumor size? Am J Med 1983; 75: 193-198.
25. Quivey JM, Castro JR, Chen GT, Moss A, Marks WM. Computerized tomography in the quantitative assessment of tumour response. Br J Cancer Suppl 1980; 4: 30-34.
26. Leung TK, Lee CM, Shen LK, Chen HC, Kuo YC, Chiou JF. Post-radiation survival time in hepatocellular carcinoma based on predictors for CT-determined, transarterial embolization and various other parameters. World J Gastroenterol 2005; 11: 1697-1699.
27. Kim YS, Lim HK, Rhim H, Lee WJ, Joh JW, Park CK. Recurrence of hepatocellular carcinoma after liver transplantation: patterns and prognostic factors based on clinical and radiologic features. AJR Am J Roentgenol 2007; 189: 352-358.
28. O'Suilleabhain CB, Poon RT, Yong JL, Ooi GC, Tso WK, Fan ST. Factors predictive of 5-year survival after transarterial chemoembolization for inoperable hepatocellular carcinoma. Br J Surg 2003; 90: 325-331.
29. Farinati F, De Maria N, Marafin C, Herszènyi L, Del Prato S, Rinaldi M, Perini L, Cardin R, Naccarato R. Unresectable hepatocellular carcinoma in cirrhosis: survival, prognostic factors, and unexpected side effects after transcatheter arterial chemoembolization. Dig Dis Sci 1996; 41: 2332-2339.
30. Ikeda K, Kumada H, Saitoh S, Arase Y, Chayama K. Effect of repeated transcatheter arterial embolization on the survival time in patients with hepatocellular carcinoma. An analysis by the Cox proportional hazard model. Cancer 1991; 68: 2150-2154.
31. Hatanaka Y, Yamashita Y, Takahashi M, Koga Y, Saito R, Nakashima K, Urata J, Miyao M. Unresectable hepatocellular carcinoma: analysis of prognostic factors in transcatheter management. Radiology 1995; 195: 747-752.
32. Mondazzi L, Bottelli R, Brambilla G, Rampoldi A, Rezakovic I, Zavaglia C, Alberti A, Idèo G. Transarterial oily chemoembolization for the treatment of hepatocellular carcinoma: a multivariate analysis of prognostic factors. Hepatology 1994; 19: 1115-1123.
33. Hopper KD, Kasales CJ, Van Slyke MA, Schwartz TA, Ten-Have TR, Jozefiak JA. Analysis of interobserver and intraobserver variability in CT tumor measurements. AJR Am J Roentgenol 1996; 167: 851-854